Cargando…
Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192172/ https://www.ncbi.nlm.nih.gov/pubmed/35707777 http://dx.doi.org/10.1055/s-0041-1736237 |
_version_ | 1784726176114147328 |
---|---|
author | Qiu, Haibo |
author_facet | Qiu, Haibo |
author_sort | Qiu, Haibo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9192172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-91921722022-06-14 Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study Qiu, Haibo Glob Med Genet Georg Thieme Verlag KG 2022-06-13 /pmc/articles/PMC9192172/ /pubmed/35707777 http://dx.doi.org/10.1055/s-0041-1736237 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Qiu, Haibo Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study |
title | Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study |
title_full | Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study |
title_fullStr | Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study |
title_full_unstemmed | Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study |
title_short | Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study |
title_sort | genomic and immunologic markers of intrinsic resistance to pembrolizumab monotherapy in microsatellite instability-high gastric cancer: observations from a prospective phase ii study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192172/ https://www.ncbi.nlm.nih.gov/pubmed/35707777 http://dx.doi.org/10.1055/s-0041-1736237 |
work_keys_str_mv | AT qiuhaibo genomicandimmunologicmarkersofintrinsicresistancetopembrolizumabmonotherapyinmicrosatelliteinstabilityhighgastriccancerobservationsfromaprospectivephaseiistudy |